Lidoplus Pain Relief Cream
NDC Package 70372-723-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Lidoplus Pain Relief (lidocaine hydrochloride) cream is for the temporary relief of pain and itching associated with minor burns, sunburn, minor cuts, scrapes, insect bites and minor skin irritations. This formulation utilizes a cream delivery system. Marketed by Centura Pharmaceuticals, Inc, this product is identified by NDC 70372-723 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
70372-723-01
Package Description
1 TUBE in 1 BOX / 118 mL in 1 TUBE
Product Code
70372-723
11-Digit Billing Format
70372072301
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Lidoplus Pain Relief
Non-Proprietary Name
Lidocaine Hydrochloride
Substance Name
Lidocaine Hydrochloride
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
LIDOCAINE HYDROCHLORIDE 40 mg/mL
Pharmacologic Class
Usage Information
For the temporary relief of pain and itching associated with minor burns, sunburn, minor cuts, scrapes, insect bites and minor skin irritations.

Regulatory & Marketing

Labeler Name
Centura Pharmaceuticals, Inc
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
12-25-2015
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (70372-723). Click a package code to view its specific billing and regulatory data.

70372-723-02
5 mL in 1 PACKET

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70372-723-01 identifies a specific commercial package of 1 tube in 1 box / 118 ml in 1 tube of Lidoplus Pain Relief, a human over the counter drug labeled by Centura Pharmaceuticals, Inc. This cream is formulated for topical use and contains lidocaine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Centura Pharmaceuticals, Inc on December 25, 2015. The current certification is valid through December 31, 2027.

How is this Centura Pharmaceuticals, Inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70372072301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70372-723-01
11-Digit CMS (5-4-2)
70372-0723-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.